Skip to main content

Advertisement

Figure 1 | BMC Medicine

Figure 1

From: Corticortophin releasing factor 2 receptor agonist treatment significantly slows disease progression in mdx mice

Figure 1

Effect of 3 months of treatment on mdx diaphragm specific force. Three-month-old mdx mice were treated by daily subcutaneous injection with the indicated compounds for 3 months and, at the end of treatment, the diaphragms were removed and evaluated for force production. Time 0, 3 month old mdx mice before treatment. Vehicle, mdx mice treated for 3 months with vehicle. Prednisone, mdx mice treated for 3 months with 1 mg/kg of prednisone. PG-873637, mdx mice treated for 3 months with 30 ug/kg of PG-873637. PG-873637 + prednisone, mdx mice treated for 3 months with the combination of 30 ug/kg PG-873637 plus 1 mg/kg prednisone.

Back to article page